Morgan Stanley’s PHI, Inc. PHII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 6941 |
|
|
2018
Q4 | $0 | Sell |
1
-300
| -100% | -$1.88K | ﹤0.01% | 6988 |
|
|
2018
Q3 | $3K | Buy |
+301
| New | +$2.72K | ﹤0.01% | 6548 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 6973 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6910 |
|
|
2017
Q4 | $0 | Buy |
+1
| New | +$12 | ﹤0.01% | 6894 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$4K | – | 6767 |
|
|
2016
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 6322 |
|
|
2016
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 6304 |
|
|
2016
Q2 | $3K | Sell |
200
-4
| -2% | -$76 | ﹤0.01% | 6347 |
|
|
2016
Q1 | $4K | Sell |
204
-1
| -0.5% | -$18 | ﹤0.01% | 6349 |
|
|
2015
Q4 | $4K | Buy |
205
+5
| +3% | +$99 | ﹤0.01% | 6440 |
|
|
2015
Q3 | $4K | Buy |
200
+195
| +3,900% | +$5.23K | ﹤0.01% | 6439 |
|
|
2015
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 7022 |
|
|
2015
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6965 |
|
|
2014
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 6995 |
|
|
2014
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6934 |
|
|
2014
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 6861 |
|
|
2014
Q1 | $0 | Buy |
+5
| New | +$194 | ﹤0.01% | 6790 |
|
Morgan Stanley's PHII Position: Q1 2019 in Review
Morgan Stanley sold out of PHI, Inc. (PHII) in Q1 2019, closing a stake of 1 share.
Morgan Stanley first reported a position in PHII in Q1 2014 and held it in 16 quarters. The position peaked at $4K in Q4 2016. 0 funds tracked by Wall St. Rank hold PHII as of Q1 2019.
- Morgan Stanley reported no remaining PHI, Inc. position as of Q1 2019 after selling out during the quarter.
- Morgan Stanley sold 1 PHI, Inc. share in Q1 2019.
- Morgan Stanley first reported a position in PHI, Inc. in Q1 2014 and held it in 16 quarters.
- Morgan Stanley's PHI, Inc. position peaked at $4K in Q4 2016.
- 0 funds tracked by Wall St. Rank held PHI, Inc. as of Q1 2019.
Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.